Clinical trial

To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1c

NCT00294723

Drugs and interventions used in this trial

6 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record liraglutide Normalized identity: liraglutideView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record glimepiride Normalized identity: glimepirideView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record liraglutide Normalized identity: liraglutideView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1c

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2006-02-01

PhasePHASE3

Conditions

Diabetesverified · MONDO: diabetes mellitus

Diabetes Mellitus, Type 2verified · MONDO: type 2 diabetes mellitus

Interventions

liraglutideDRUG · verified · RxNorm: liraglutide

glimepirideDRUG · verified · RxNorm: glimepiride

liraglutideDRUG · verified · RxNorm: liraglutide

placeboDRUG

Sponsors & collaborators

Novo Nordisk A/Slead sponsor

Mapped research locations

DallasTexas, United States5 HoustonTexas, United States4 AtlantaGeorgia, United States4 ChicagoIllinois, United States2 St LouisMissouri, United States2 JacksonvilleFlorida, United States2 Oklahoma CityOklahoma, United States2 LexingtonKentucky, United States2 Mexico CityMexico2 MedfordOregon, United States2 New YorkNew York, United States1 PhiladelphiaPennsylvania, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00294723 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.